Keros Therapeutics (KROS.US) Latest Stock News - Major News Analysis

Quote List Quote List

Event Tracking

Dec18

Wells Fargo Analyst Maintains Buy Rating and Sets Price Target for Keros Therapeutics

17:02

Nov12

Oppenheimer Analyst Maintains Buy Rating on Keros Therapeutics

13:02

Nov6

H.C. Wainwright Reiterates Buy Rating on Keros Therapeutics

11:51

Keros Therapeutics released FY2025 Q3 earnings on November 5 (EST), actual revenue USD 14.26 M (forecast USD 4.222 M), actual EPS USD -0.18 (forecast USD -1.02)

04:00

Keros Therapeutics released FY2025 9 Months Earnings on November 5 (EST), actual revenue USD 243.68 M, actual EPS USD 2.68

04:00

Oct20

Keros Therapeutics Launches Stock Repurchase Program

14:02

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 14.26 M, Net Income -7.28 M, EPS -0.18

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 18.17 M, Net Income -30.7 M, EPS -0.7599

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 211.25 M, Net Income 148.45 M, EPS 3.62

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change